Please ensure Javascript is enabled for purposes of website accessibility

Editas Medicine(EDIT)

Nasdaq Global Select

Editas Medicine Stock Quote
$40.36 -$2.77 -6.4%
Price as of March 4, 2021, 9:00 p.m. EST View Interactive EDIT Charts

Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.

Interactive Chart

News & Analysis: Editas Medicine

The Fool has written over 200 articles on Editas Medicine.


Market Moves



Is Editas Medicine a Buy?

Could this maverick biotech discover the cure for several debilitating rare diseases?